• 首页期刊简介编委会刊物订阅专栏专刊电子刊广告合作联系我们English
引用本文:黄凌斐,杨巨飞,高鹏,王慧娟,朱正怡,倪映华,方罗.COVID-19疫情下慢病患儿的药学服务模式[J].中国现代应用药学,2020,37(5):555-559.
HUANG Lingfei,YANG Jufei,GAO Peng,WANG Huijuan,ZHU Zhengyi,NI Yinghua,FANG Luo.Facing the COVID-19 Outbreak: Pharmaceutical Care Model for Children with Chronic Disease[J].Chin J Mod Appl Pharm(中国现代应用药学),2020,37(5):555-559.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2114次   下载 1401 本文二维码信息
码上扫一扫!
分享到: 微信 更多
COVID-19疫情下慢病患儿的药学服务模式
黄凌斐, 杨巨飞, 高鹏, 王慧娟, 朱正怡, 倪映华, 方罗
浙江大学医学院附属儿童医院、国家儿童健康与疾病临床医学研究中心药剂科, 杭州 310052
摘要:
2019年12月我国发生新型冠状病毒感染,儿童、婴幼儿甚至新生儿均有感染病例。此疫情下,如何开展高质量的儿科药学服务、保障患儿安全用药,是目前儿科药师的重点工作。因此,本文基于疫情期间儿童慢病用药特点与特殊需求,结合长期慢病患儿的药学服务经验和疫情期间的实际工作,从慢病患儿新型冠状病毒感染用药资料库的构建、线上线下相结合药学服务的开展、分级药学服务策略的探索等方面归纳相关药学服务模式,以期为特殊时期儿童慢病服务开展提供参考。
关键词:  新型冠状病毒肺炎  儿童  慢病  药学服务
DOI:10.13748/j.cnki.issn1007-7693.2020.05.007
分类号:R969.3
基金项目:浙江大学新型冠状病毒肺炎(COVID-19)应急科研专项资金;浙江省151人才工程(方罗);浙江省医坛新秀培养工程(方罗)
Facing the COVID-19 Outbreak: Pharmaceutical Care Model for Children with Chronic Disease
HUANG Lingfei, YANG Jufei, GAO Peng, WANG Huijuan, ZHU Zhengyi, NI Yinghua, FANG Luo
Department of Pharmacy, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
Abstract:
Since December 2019, an epidemic called coronavirus disease 2019 or COVID-19 quickly spread across China, and a number of pediatric cases have been reported. Facing the COVID-19 outbreak, it is more difficult to provide pharmaceutical care for children with chronic disease. How to reduce the risk of cross-infection while ensuring the safety of medication is a problem that pediatric pharmacists should pay close attention to. Therefore, specific pharmaceutical care model has been carried out in our hospital during this particular period; and the correlative experience is summarized in three aspects: construction of drug database for COVID-19; development of internet pharmaceutical services; and multi-hierarchical pharmaceutical care strategy; and finally to provide a reasonable reference for other healthcare institutions.
Key words:  COVID-19  children  chronic disease  pharmaceutical care
扫一扫关注本刊微信